Z3A.17
17 weeks gestation of pregnancy
Clinical Classification Guidelines
Medical Intelligence & Overview
Reaching 17 weeks of pregnancy marks an important milestone in the journey to parenthood. During this stage, the fetus continues to develop rapidly, and expectant mothers often begin to experience noticeable changes. This period, classified under ICD-10 code Z3A.17, refers specifically to pregnancies that are at 17 weeks gestation, offering insights into fetal growth, maternal health, and what to expect during this time.
Causes & Symptoms
Clinical Causes: Natural conception following ovulation Assisted reproductive technologies such as in vitro fertilization (IVF) Multiple pregnancies (twins, triplets, etc.) can also reach this stage if conceived through fertility treatments Healthy maternal lifestyle and prenatal care support ongoing pregnancy development
Key Symptoms: Increased abdominal size as the uterus enlarges Fetal movements becoming noticeable, often described as flutters or kicks Changes in breast size and tenderness Nausea and food cravings may decrease or continue Possible backache or pelvic discomfort Frequent urination due to increased pressure on the bladder Skin changes such as stretch marks or pigmentation changes
Diagnostic & Treatment
Diagnosis Path: Diagnosis of 17 weeks gestation is primarily based on obstetric ultrasound, which measures fetal size and estimates gestational age with high accuracy. Healthcare providers may also utilize the following during assessment:
Treatment Protocols: Management at 17 weeks typically involves continued prenatal care, including regular check-ups, ultrasound assessments, and screenings to monitor fetal growth and maternal health. Specific recommendations include:
Clinical Advice & FAQs
Billing Guidance
Is Z3A.17 a billable ICD-10 code?
Yes, Z3A.17 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report Z3A.17?
Clinical documentation must specify the nature of 17 weeks gestation of pregnancy and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
